Determination of palonosetron in human plasma by ultra performance liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
Authors:
- Feng QinFQFeng Qin
- Dan WangDWDan Wang
- Ning LiNLNing Li
- Famei LiFLFamei Li
- Zhili XiongZXZhili Xiong
- 5 January 2012
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 57, 13-18
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Sensitive and Selective LC-MS-MS Assay for the Quantification of Palonosetron in Human Plasma and Its Application to a Pharmacokinetic StudyChromatographia, 2008
- Determination of palonosetron in human plasma by liquid chromatography–electrospray ionization-mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- Evaluation of Safety and Pharmacokinetics of Consecutive Multiple‐Day Dosing of Palonosetron in Healthy SubjectsThe Journal of Clinical Pharmacology, 2005
- Pharmacokinetics, metabolism and excretion of intravenous [l4C]‐palonosetron in healthy human volunteersBiopharmaceutics & Drug Disposition, 2004
- Pharmacokinetic and Safety Evaluation of Palonosetron, a 5‐Hydroxytryptamine‐3 Receptor Antagonist, in U.S. and Japanese Healthy SubjectsThe Journal of Clinical Pharmacology, 2004